Therapeutic compounds

US9050344B2 · kind B2 · utility

Assignee

• Gilead Sciences, Inc. · US

Inventors

• Gediminas Brizgys · Redwood City, US
• Chien-Hung Chou · Dublin, US
• Randall L. Halcomb · Foster City, US
• Yunfeng Eric Hu · Hillsborough, US
• Qi Liu · Beijing, CN
• John R. Somoza · San Francisco, US
• Winston C. Tse · Redwood City, US
• Jennifer R. Zhang · Union City, US

Key dates

• Filing date: Jan 9, 2014
• Grant date: Jun 9, 2015
• Expiry date: Jan 9, 2034

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D491/107
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds of formula I:or pharmaceutically acceptable salts thereof are disclosed. Also disclosed are pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I, intermediates useful for preparing compounds of formula I and therapeutic methods for treating a Retroviridae viral infection including an infection caused by the HIV virus.